Trabectedin as a single-agent treatment of advanced breast cancer after anthracycline and taxane treatment: a multicenter, randomized, phase II study comparing 2 administration regimens (Q85344344)
Jump to navigation
Jump to search
scientific article published on 15 August 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Trabectedin as a single-agent treatment of advanced breast cancer after anthracycline and taxane treatment: a multicenter, randomized, phase II study comparing 2 administration regimens |
scientific article published on 15 August 2014 |
Statements
Trabectedin as a single-agent treatment of advanced breast cancer after anthracycline and taxane treatment: a multicenter, randomized, phase II study comparing 2 administration regimens (English)
Lori J Goldstein
Jayne Gurtler
Salvatore A Del Prete
Sergei Tjulandin
Vladimir F Semiglazov
Eliel Bayever
Bart Michiels
15 August 2014